18/10/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

18/10/2023

Oct 18, 2023, 16:51 | Blog
Jessica Clerc: Exciting updates from the World Cancer Leaders' Summit 2023 in Long Beach, CA!
Jessica Clerc, Partnership Manager at the Union for International Cancer Control (UICC), recently shared on…
Oct 18, 2023, 16:45 | Blog
Daniel Bastardo Blanco: Dr Brad Muller invites ALL patients and parents of children with ALL to join him in the upcoming patient webinar
Quoting Daniel Bastardo Blanco, the Manager of Together by St. Jude online resource for St.…
Oct 18, 2023, 16:43 | Societies
All regular abstracts and posters can be found online - The European Society for Medical Oncology
The European Society for Medical Oncology recently shared on its X/Twitter page: "All regular abstracts…
Oct 18, 2023, 16:43 | Drugs
U.S. FDA approved pembrolizumab for NSCLC as single-agent for adjuvant and in combination with chemo for neoadjuvant settings - American Association for Cancer Research
American Association for Cancer Research recently shared on its Twitter page: "Today, the U.S. FDA…
Oct 18, 2023, 16:42 | Blog
Andreas Charalambous: Secondary Prevention is key when it comes to lung cancer control.
Andreas Charalambous, President of the European Cancer Organisation, recently shared on LinkedIn: "Secondary Prevention is…
Oct 18, 2023, 16:41 | Societies
ESMO-GROW, the first oncology-specific reporting guidance for RWE studies - The European Society for Medical Oncology
The European Society for Medical Oncology recently shared on its X/Twitter page: "ESMO announces the…
Oct 18, 2023, 16:36 | Drugs
Eric Feigl-Ding: Corrupt “SUE TO DELAY” big pharma shenanigan
Eric Feigl-Ding, Faculty, Chair of Public Health, Chief of COVID Task Force at New England…
Oct 18, 2023, 16:32 | Blog
We’re currently funding $78 million in breast cancer-specific research through 160 grants - American Cancer Society
American Cancer Society shared on X/Twitter: "We’re currently funding $78 million in breast cancer-specific research…
Oct 18, 2023, 16:28 | Blog
We are delighted to be collaborating with leading biotechnology company Amgen - World Child Cancer
Quoting World Child Cancer on LinkedIn: "We are delighted to be collaborating with leading biotechnology…
Oct 18, 2023, 16:24 | Blog
Florian Lordick: Very honoured to receive the DGHO best abstract award 2023 for the Eortc1708 Vestige study
Florian Lordick, Professor of Medicine at University of Leipzig, shared on LinkedIn: "Very honoured to…
All: 33 Posts: 21 - 30
Special Coverage